-
Company Profile
BPH Energy Ltd – Company Profile
BPH Energy Ltd (BPH), is a stage funding, project management, and commercialization strategies provider. It carries out the development and commercialization of biomedical research and technologies, medical cannabis and oil and gas exploration. The company’s principal investment activities include: Cortical Dynamics Brain Anaesthesia Response (BAR) Monitor; Diagnostic Array Systems; HLS5. BPH has partnerships with various academic institutions and companies including The Western Australian Institute for Medical Research, Swinburne University of Technology, The Royal Melbourne Institute for Technology, Molecular Discovery Systems,...
Add to Basket -
Product Insights
Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Non-Small Cell Lung Cancer Pipeline Drugs Market Report Overview Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. NSCLC (malignancy) originates in the tissues of the lungs or the cells lining the airways. Symptoms usually occur in the later stages of the disease, and include a persistent cough that may get worse over time, trouble breathing or shortness of breath, constant chest pain or discomfort, bloody phlegm or spit (sputum), fatigue and weakness, and unintentional weight...
-
Product Insights
Progressive Supranuclear Palsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Progressive supranuclear palsy, also called Steele-Richardson-Olszewski syndrome is a rare neurodegenerative disease that leads to difficulty with balance, movement, vision, speech and swallowing. Symptoms include fatigue, headaches, dizziness, depression, Parkinsonism, behavioral, cognitive, and gait disturbances that cause imbalance and arthralgias. The only proven risk factor for progressive supranuclear palsy is age. Treatment includes anticholinergic medications. The Progressive Supranuclear Palsy pipeline drugs market research report provides comprehensive information on the therapeutics under development for Progressive Supranuclear Palsy, complete with analysis by...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – everolimus
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry everolimus Drug Details Everolimus is under development for the treatment of intractable refractory epilepsy...
-
Product Insights
Net Present Value Model: Thiola/Thiola EC
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Thiola/Thiola EC Drug Details Tiopronin (Thiola)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AZD-0328
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry AZD-0328 Drug Details AZD0328 is under development for the treatment of mild cognitive impairment...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – TPI-287
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry TPI-287 Drug Details ARC-100 (TPI 287) is under development for the treatment of Alzheimer's...
-
Product Insights
Spinal Surgery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Spinal surgery includes devices used in the surgical treatment of degenerative disc diseases, intra-vertebral fractures, and scoliosis. The Spinal Surgery pipeline market research report provides comprehensive information about the Spinal Surgery pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Sector Analysis
Neuromodulation Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
The Neuromodulation Devices pipeline market research report provides comprehensive information about the Neuromodulation Devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Corticobasal Degeneration (CBD-CBGD-Cortical Basal Ganglionic Degeneration) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Corticobasal Degeneration (CBD/CBGD/Cortical Basal Ganglionic Degeneration) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Corticobasal Degeneration (CBD/CBGD/Cortical Basal Ganglionic Degeneration) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Corticobasal Degeneration (CBD/CBGD/Cortical Basal Ganglionic Degeneration), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics,...